June 2026– date –
-
Bioreactor Turndown Ratios in High-Density Perfusion Systems Revolutionize N-1 Perfusion Programs
Drug Discovery News USA Overview Optimizing bioreactor turndown ratios in high-density perfusion systems is revolutionizing N-1 perfusion programs. Bioreactors with turndown ratios of 10:1 or more enable both seed and production cultures... -
ENCell Secures US Clinical Manufacturing Contract for Ingenium’s AML-Targeting NK Cell Therapy, ‘gengleucel’
KBR South Korea Overview ENCell, a CDMO specializing in cell and gene therapies, has secured a manufacturing contract for Ingenium Therapeutics' allogeneic NK cell therapy candidate, 'gengleucel,' for U.S. clinical trials. This therapy t... -
Biosero Unveils Self-Correcting Bioprocessing Platform to Accelerate Pharma R&D Automation
Biosero USA Overview Biosero has introduced a self-correcting platform advancing bioprocessing automation in pharmaceutical R&D. Future systems are projected to adapt protocols in real-time based on process analytical data, learning ... -
US Policy Shift Reshapes Biomanufacturing Supply Chain: Fujifilm Diosynth, Japan Government Drive Asia’s Rise as Key Hub
BioProcess Insider USA Overview The U.S. policy pivot regarding China's biotechnology sector is driving a global biomanufacturing supply chain restructuring. Fujifilm Diosynth Biotechnologies is pursuing over $4 billion in global expansi... -
STEMCELL Technologies Launches Human iPSC-Derived Hepatic Organoids, Advancing Liver Research
STEMCELL Technologies Canada Overview STEMCELL Technologies has launched human iPSC-derived hepatic organoid products to advance research into liver development, drug-induced liver injury, hepatotoxicity, and metabolism. These organoids ... -
Laboratories Accelerate Shift to Automated Adherent and Suspension Cell Culture Platforms with CellXpress.ai Supporting Diverse Cell Types
News-Medical.Net UK Overview Laboratories are rapidly transitioning to automated adherent and suspension cell culture platforms like the CellXpress.ai system. This platform supports diverse cell types including 2D adherent, suspension, a... -
Lonza, Samsung Biologics, and Catalent Lead 2026 Biologics CDMO Market, Driven by AI Manufacturing & APAC Expansion
Towards Healthcare Unknown Overview Lonza, Samsung Biologics, and Catalent are identified as key players leading the 2026 biologics CDMO market. Lonza excels in end-to-end multi-modality and scientific innovation, Samsung Biologics in la... -
Immersive Biotech Energy Natural Resources Platform Market Leverages AI and Sensor Networks for Optimization
Digital Journal Canada Overview This article provides an overview of a market research report published by Digital Journal. The Immersive Biotech Energy Natural Resources Platform market utilizes AI-powered machine learning models to int... -
Bioprocessing’s ‘AI’ Demystified: Machine Learning Integrates with Existing Tech, Emphasizing Real-time Data at 2026 Summit
Mewburn Ellis UK Overview Discussions at the 2026 Global Bioprocessing & Biotechnology Summit clarified that 'AI' in bioprocessing refers not to large language models, but to the integration of machine learning into existing modeling... -
CellXpress.ai System Automates Brain Organoid Generation from iPSCs, Boosting Reproducibility and Efficiency for Neuroscience Research
News-Medical.Net UK Overview The CellXpress.ai automated cell culture system has been developed for the automated generation of brain organoids from iPSCs. Integrating liquid handlers, incubators, imagers, and machine learning-assisted i...
